[Liver damage during use of busulfan]
- PMID: 2797253
[Liver damage during use of busulfan]
Erratum in
- Ned Tijdschr Geneeskd 1989 Sep 16;133(37):1864
Abstract
A man aged 57 years with a chronic megakaryocytic granulocytic myelosis, treated with an intermittent low-dose busulfan schedule, developed intrahepatic cholestasis. We advise to do liver biopsy, if possible, to differentiate between busulfan hepatotoxicity and leukaemic activity. In the former case, it may be necessary to stop busulfan.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical